Prophylactic Antiplatelets in ICA Aneurysm
Conservative Management of Unruptured ICA Aneurysms
- The American College of Chest Physicians recommends aspirin 75-100 mg daily for patients with unruptured ICA aneurysms who are being observed without intervention, following a Grade 2B recommendation, to reduce overall cardiovascular mortality and stroke risk 1, 2, 3, 4
- Aspirin reduces total mortality over 10 years regardless of cardiovascular risk profile in patients with underlying atherosclerotic vascular disease, with a benefit that must be weighed against bleeding risk 1, 5
- Low-dose aspirin (75-100 mg daily) is superior to higher doses for vascular protection, with the Aspirin and Carotid Endarterectomy trial demonstrating significantly lower rates of stroke, MI, and death compared to high-dose aspirin 1, 3, 4, 6
Aneurysms Undergoing Endovascular Treatment
- Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel should be continued for 1-3 months post-procedure, then transitioned to single antiplatelet therapy indefinitely, according to Praxis Medical Insights 7
Critical Pitfalls to Avoid
- Regular surveillance imaging is essential in patients with ICA aneurysms on aspirin therapy to detect silent progression of disease, as aspirin may mask symptoms of progressive carotid atherosclerosis 7
- Do not initiate aspirin in patients at very high bleeding risk without careful consideration of cardiovascular benefit versus hemorrhagic risk, according to the American College of Chest Physicians 1
Monitoring Strategy
- Annual follow-up is mandatory to assess cardiovascular risk factors, treatment compliance, and neurological symptoms, with duplex ultrasound surveillance within the first month recommended after endovascular treatment 7
- Hemoglobin levels and clinical bleeding parameters should be monitored in patients on antiplatelet therapy, according to Praxis Medical Insights 8